A randomized study comparing oral and standard regimens for metastatic breast cancer

Oncology Reports

Volumn 8, Issue 5, 2001, Pages 1067-1071

  Kodama, Hiroshi ^a  

^a Kyoto Police Hospital   (Japan)

Author keywords

Capccitabinc; Cyclophosphamidc; Doxifluridmc; Mctastatic breast cancer; Medroxyprogesteronc acetate; Oral therapy; Phase iii study; Standard therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXIFLURIDINE; DOXORUBICIN; DRUG DERIVATIVE; FLOXURIDINE; FLUOROURACIL; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXORUBICIN; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; SURVIVAL RATE;

EID: 17344390833     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Cancer statistics in Japan Editorial board: Figures and graphs. In: Cancer Statistics in Japan. Kakizoc T (cd). Foundation for Promotion of Cancer Research, Tokyo, pp9-29, 1997.
2. Kanda K, Yamagata J, Takcnaka K, Tashiro II and Nomura Y: Combination chemotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin cyclophosphamidc (FAC). Jpn J Cancer Chcmolhcr 8: 749-756, 19S1.
3. Abc O, Izuo M, Enomoto K, Kubo K, Koyama H, Sakai K. et ai. Combination chemotherapy of cyclophosphamidc adriamycin and 5-fluorouracil (CAP) in advanced and recurrent breast cancer. Jpn J Cancer Chcmolhcr 9: 866-873, 1982.